Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT05303519 |
Title | Safusidenib Phase 2 Study in IDH1 Mutant Glioma |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | AnHeart Therapeutics Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
St. Joseph's Hospital and Medical Center | RECRUITING | Phoenix | Arizona | 85013 | United States | Details |
Massachusetts General Hospital | RECRUITING | Boston | Massachusetts | 02214 | United States | Details |
Dana-Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
Columbia University Medical Center | RECRUITING | New York | New York | 10032 | United States | Details |
Memorial Sloan Kettering Cancer Center | RECRUITING | New York | New York | 10065 | United States | Details |
Duke Cancer Institute | NOT_YET_RECRUITING | Durham | North Carolina | 27710 | United States | Details |
Cleveland Clinic | RECRUITING | Cleveland | Ohio | 44106 | United States | Details |
Huntsman Cancer Insititute, University of Utah | RECRUITING | Salt Lake City | Utah | 84112 | United States | Details |
UVA Health, Emily Couric Clinical Cancer Cente | RECRUITING | Charlottesville | Virginia | 22903 | United States | Details |